- In May 2024, Teleflex Incorporated announced the launch of its next-generation suprapubic catheterization kits, featuring improved ergonomic design and infection-control enhancements. This innovation is aimed at reducing catheter-associated complications and enhancing ease of insertion in both hospital and ambulatory settings. The development highlights Teleflex’s ongoing commitment to advancing urological care through safe and user-friendly solutions
- In March 2024, Coloplast A/S expanded its catheter production facility in Hungary to meet the rising global demand for suprapubic and intermittent catheters. The expansion supports increased supply capabilities in Europe and emerging markets and reflects Coloplast’s strategy to localize manufacturing and improve product accessibility for patients and care providers
- In February 2024, B. Braun Melsungen AG partnered with multiple European hospitals to initiate clinical trials assessing the long-term performance and safety of its antimicrobial-coated suprapubic catheters. This initiative is part of the company’s broader focus on reducing healthcare-associated infections and promoting evidence-based adoption of its catheter solutions
- In January 2024, Medline Industries, LP launched a training and education program across U.S. hospitals to improve healthcare professionals’ proficiency in suprapubic catheter insertion and care. The program aims to enhance patient outcomes by reducing procedural errors and promoting best practices in long-term urinary management
- In December 2023, Hollister Incorporated introduced a patient-focused digital tool designed to help users manage their suprapubic catheters at home. The mobile app provides reminders, care guidelines, and remote consultation access, supporting the increasing shift toward home-based healthcare and empowering patients with greater autonomy over their urinary care
